BMO Capital Markets Has Lowered Expectations for Vertex …
Dec 20, 2024 · BMO Capital Markets lowered their target price on shares of Vertex Pharmaceuticals from $566.00 to $520.00 and set an "outperform" rating on the stock in a …
OFF
BMO Capital Markets Has Lowered Expectations For Vertex …
1 day from now
Dec 20, 2024 · BMO Capital Markets lowered their target price on shares of Vertex Pharmaceuticals from $566.00 to $520.00 and set an "outperform" rating on the stock in a …
marketbeat.com
OFF
BMO Capital Markets Has Lowered Expectations For Vertex …
1 day from now
Dec 22, 2024 · Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report) had its price target cut by investment analysts at BMO Capital Markets from $566.00 to $520.00 in a report …
defenseworld.net
OFF
BMO Cuts Vertex Target To $520, Stays Positive On Drug Outlook
1 day from now
Dec 20, 2024 · BMO (TSX: BMO) Capital Markets anticipates that the approval and subsequent launch of suzetrigine for acute pain, expected in January 2025, will surpass current market …
investing.com
OFF
BMO Cuts Vertex Target To $520, Stays Positive On Drug Outlook
1 day from now
Dec 20, 2024 · BMO Capital Markets anticipates that the approval and subsequent launch of suzetrigine for acute pain, expected in January 2025, will surpass current market expectations.
investing.com
OFF
Vertex Pharmaceuticals Price Target Lowered To $520 From $566 At …
1 day from now
Dec 20, 2024 · BMO Capital lowered the firm’s price target on Vertex Pharmaceuticals (VRTX) to $520 from $566 but keeps an Outperform rating on the shares. The company’s Suzetrigine …
nasdaq.com
OFF
Vertex Stability Amid Challenges: A Cautious Hold ... - Markets …
1 day from now
Jun 12, 2024 · BMO Capital analyst Daniel Jester maintained a Hold rating on Vertex (VERX – Research Report) today and set a price target of $35.00.. Daniel Jester has given his Hold …
businessinsider.com
OFF
What Analysts Are Saying About Vertex Pharmaceuticals Stock
1 day from now
Oct 1, 2024 · The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $500.53, a high estimate of $600.00, and a low estimate of $376.00.
nasdaq.com
OFF
Vertex Shares Target Lifted To $52 On Growth Optimism
1 day from now
Nov 6, 2024 · The updated estimates and price target suggest that BMO Capital Markets sees Vertex as maintaining a steady performance, with potential upside from new growth vectors …
investing.com
OFF
HC Wainwright Issues Pessimistic Forecast For Vertex …
1 day from now
6 days ago · Vertex Pharmaceuticals (NASDAQ:VRTX – Free Report) had its price objective cut by HC Wainwright from $600.00 to $535.00 in a research note released on Friday, …
americanbankingnews.com
OFF
BMO Cuts Vertex Target To $520, Stays Positive On Drug Outlook
1 day from now
Dec 20, 2024 · BMO Capital Markets anticipates that the approval and subsequent launch of suzetrigine for acute pain, expected in January 2025, will surpass current market expectations. …
investing.com
OFF
Stifel Nicolaus Issues Positive Forecast For Vertex ... - MarketBeat
1 day from now
Dec 18, 2024 · BMO Capital Markets lifted their price objective on Vertex from $42.00 to $52.00 and gave the company a "market perform" rating in a research note on Thursday, November …
marketbeat.com
OFF
BMO Capital Markets Issues Pessimistic Forecast For Compass …
1 day from now
Dec 18, 2024 · BMO Capital Markets decreased their price target on Compass Minerals International from $20.00 to $18.00 and set a "market perform" rating for the company in a …
marketbeat.com
Install CouponFollow Extension on Chrome
Install the CouponFollow extension to search for discount codes when shopping the fastest!
Install CouponFollow Chrome Extension
Listing Store by Characters
